Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The urological management of neurological patients is crucial to ensure patient survival and improve their quality of life. The natural progression of disease in central neurological bladders typically involves a major decrease in both bladder capacity and contractile function, often necessitating cystectomy. One alternative to urinary reconstruction is continent catheterizable urinary diversion (e.g., Miami pouch, Mitrofanoff, Monti, etc.). A common complication of these diversions is the formation of intravesical stones, which require surgical management. When the urethra allows access to the urinary diversion, the gold standard is transurethral lithotripsy using a cystoscope; however, when this is not feasible, several techniques exist, albeit without clear recommendations.
In the literature, the most frequently discussed techniques include bladder dilation, percutaneous bladder lithotripsy using nephrolithotripsy (NLPC) equipment, and trans-stomal lithotripsy using a flexible fibroscope. Although bladder dilation has shown higher complication rates in case series compared to other techniques, there is very little comparative data between the percutaneous and trans-stomal methods in the literature. Case series indicate a higher risk of fistula formation with the percutaneous technique for urinary diversions performed in the gastrointestinal tract as compared to native bladder diversions, and a risk of stenosis or loss of continence with the trans-stomal technique.
At the Hospices Civils de Lyon (HCL), the Urology Department of the Lyon Sud Hospital has expertise in neuro-urology with a large cohort of patients presenting continent catheterizable urinary diversions, and the Urology Department of Edouard Herriot Hopspital has expertise in NLPC, particularly with the use of mini-NLPC (smaller nephroscope diameter). The synergy between these two departments has enabled the creation of a large cohort, with frequent use of the percutaneous route for bladder lithotripsy and, since 2020, the trans-stomal route using mini-NLPC equipment.
Therefore, given the limited data available in the literature, this retrospective comparative study would provide stronger evidence to improve the management of these patients.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Trans-Stomal Bladder Lithotripsy Using Mini-Percutaneous Equipment | Patient operated on using Trans-Stomal Bladder Lithotripsy Using Mini-Percutaneous Equipment |
| |
| Trans-stomial bladder lithotripsy using flexible fibroscope | Patient operated on using Trans-stomial bladder lithotripsy using flexible fibroscope |
| |
| Percutaneous cystholithotripsy | Patient operated on using Percutaneous cystholithotripsy |
| |
| Open Cystolithotomy | Patient operated on using Open Cystolithotomy |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| QoL-DUCC questionnaire | Other | Patients of all groups will answer this quality of life questionnaire that has been specially designed for the study |
|
| Measure | Description | Time Frame |
|---|---|---|
| Residual stone size greater than 4mm postoperatively. | Residual stone size greater than 4mm postoperatively will be investigated on imaging control | Up to 7 days after surgery |
| Measure | Description | Time Frame |
|---|---|---|
| Qol-DUCC questionnaire answers | answers to the Qol-DUCC questionnaire will be analysed to assess patient quality of life | At inclusion |
| Qualiveen questionnaire score | The Qualiveen questionnaire score will be analysed to assess patient quality of life, for individuals who have urinary disorders. It contains 4 domains: Limitations/Inconvenience, Constraints/Restrictions, Fears, Feelings/Impact on Daily Life. The questionnaire is based on a 5-point Likert scale (0 = "not at all", 4 = "extremely"). Each domain score is calculated as an average of the scores for the domain items. An overall (averaged) score can also be calculated. Lower scores on this questionnaire indicate higher quality of life. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Major patients with a continent cutaneous urinary diversion, followed in the urology departments of Lyon Sud Hospital and Édouard Herriot Hospital
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Nadia ABID, MD, PhD | Contact | +33 4 72 11 96 75 | nadia.abid@chu-lyon.fr | |
| Léonard TOTARO, MD | Contact | +33 613230009 | leonard.totaro@chu-lyon.fr |
| Name | Affiliation | Role |
|---|---|---|
| Nadia ABID, MD, PhD | Hospices Civils de Lyon | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hôpital Edouard Herriot | Lyon | 69003 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Qualiveen Questionnaire | Other | Patients of all groups will answer this validated quality of life questionnaire |
|
| At inclusion |
| Hôpital Lyon Sud | Pierre-Bénite | 69495 | France |
|
| ID | Term |
|---|---|
| D001744 | Urinary Bladder Calculi |
| ID | Term |
|---|---|
| D001745 | Urinary Bladder Diseases |
| D014570 | Urologic Diseases |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D014545 | Urinary Calculi |
| D052878 | Urolithiasis |
| D052801 | Male Urogenital Diseases |
| D002137 | Calculi |
| D020763 | Pathological Conditions, Anatomical |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided